Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Retained Earnings (2023 - 2025)

Bioharvest Sciences has reported Retained Earnings over the past 3 years, most recently at -$107.6 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 11.55% year-over-year to -$107.6 million; the TTM value through Dec 2025 reached -$107.6 million, down 11.55%, while the annual FY2025 figure was -$107.6 million, 11.55% down from the prior year.
  • Retained Earnings was -$107.6 million for Q4 2025 at Bioharvest Sciences, down from -$105.3 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$83.5 million in Q4 2023 and bottomed at -$107.6 million in Q4 2025.
  • The 3-year median for Retained Earnings is -$96.4 million (2024), against an average of -$97.2 million.
  • Year-over-year, Retained Earnings dropped 15.46% in 2024 and then fell 2.42% in 2025.
  • Over 3 years, Retained Earnings stood at -$83.5 million in 2023, then fell by 15.46% to -$96.4 million in 2024, then dropped by 11.55% to -$107.6 million in 2025.
  • The last three reported values for Retained Earnings were -$107.6 million (Q4 2025), -$105.3 million (Q3 2025), and -$102.8 million (Q2 2025) per Business Quant data.